Edgewise Therapeutics Inc. (EWTX) NASDAQ

$5.67 -0.68 (-10.71%)

Market Cap: $281.09M

As of 05/25/22 04:00 PM EDT. Market closed.

(EWTX)

Edgewise Therapeutics Inc. (EWTX) NASDAQ

$5.67 -0.68 (-10.71%)

Market Cap: $281.09M

As of 05/25/22 04:00 PM EDT. Market closed.

Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of innovative treatments for severe, rare muscle disorders for which there is significant unmet medical need. Guided by its holistic drug discovery approach to targeting the muscle as an organ, Edgewise has combined its foundational expertise in muscle biology and small ... read more

Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of innovative treatments for severe, rare muscle disorders for which there is significant unmet medical need. Guided by its holistic drug discovery approach to targeting the muscle as an organ, Edgewise has combined its foundational expertise in muscle biology and small molecule engineering to build its proprietary, muscle focused drug discovery platform. Edgewise’s platform utilizes custom-built high throughput and translatable systems that measure integrated muscle function in whole organ extracts to identify small molecule precision medicines regulating key proteins in muscle tissue, initially focused on addressing rare neuromuscular and cardiac diseases. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Medicinal and Botanical Manufacturing
URL
Address
.
Sector
Manufacturing
Industry
Medicinal and Botanical Manufacturing
Full Time Employees
19
Address
.
PRICE CHART
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
KEY STATS
Open
$6.20
Previous Close
$6.35
Days Range
$5.41 - $6.29
52 week range
$5.41 - $29.34
Volume
248,852
Avg. Volume (30 days)
257,988
Market Cap
$281.09M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
49,575,689
Open
$6.20
Previous Close
$6.35
Days Range
$5.41 - $6.29
52 week range
$5.41 - $29.34
Volume
248,852
Avg. Volume (30 days)
257,988
Market Cap
$281.09M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
49,575,689

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR EDGEWISE THERAPEUTICS INC
Owner Relationship Date Transaction Cost # Shares Value($) Total Shares Form 4
Carruthers R Michael Chief Financial Officer May 23, 2022 Option Exercise $0.71 9,000 6,390 12,000 May 25, 2022, 06:11 PM
ORBIMED ADVISORS LLC Director May 18, 2022 Buy $7.21 138,000 994,980 13,497,456 May 20, 2022, 04:38 PM
Thompson Peter A. Director May 18, 2022 Buy $7.21 138,000 994,980 13,497,456 May 20, 2022, 04:32 PM
MOORE JOHN R General Counsel May 16, 2022 Sale $7.42 10,800 80,146 3,000 May 18, 2022, 05:15 PM
MOORE JOHN R General Counsel Jan 21, 2022 Option Exercise $0.71 5,400 3,834 12,362 Jan 25, 2022, 06:50 PM
MOORE JOHN R General Counsel Dec 28, 2021 Option Exercise $0.71 5,400 3,834 6,962 Dec 30, 2021, 05:51 PM
Russell Alan J Chief Scientific Officer Nov 30, 2021 Option Exercise $0.22 172,585 37,815 172,585 Dec 01, 2021, 06:20 PM
Russell Alan J Chief Scientific Officer Nov 15, 2021 Sale $19.11 479 9,155 38 Nov 17, 2021, 06:05 PM
Russell Alan J Chief Scientific Officer Nov 12, 2021 Sale $19.51 8,562 167,074 479 Nov 12, 2021, 05:24 PM
Russell Alan J Chief Scientific Officer Nov 11, 2021 Sale $19.93 19,276 384,238 12,722 Nov 12, 2021, 05:24 PM
Russell Alan J Chief Scientific Officer Nov 10, 2021 Sale $19.73 12,326 243,170 28,897 Nov 12, 2021, 05:24 PM
Russell Alan J Chief Scientific Officer Nov 09, 2021 Sale $20.09 29,576 594,306 53,355 Nov 12, 2021, 05:24 PM
Russell Alan J Chief Scientific Officer Nov 08, 2021 Sale $20.16 9,017 181,824 70,219 Nov 08, 2021, 07:11 PM
Russell Alan J Chief Scientific Officer Nov 05, 2021 Sale $19.62 13,042 255,907 92,272 Nov 08, 2021, 07:11 PM
Russell Alan J Chief Scientific Officer Nov 04, 2021 Sale $19.76 7,392 146,092 92,278 Nov 08, 2021, 07:11 PM
Russell Alan J Chief Scientific Officer Nov 03, 2021 Sale $18.18 26,184 476,096 105,032 Nov 03, 2021, 07:00 PM
Russell Alan J Chief Scientific Officer Nov 02, 2021 Sale $17.43 17,519 305,360 125,854 Nov 03, 2021, 07:00 PM
Russell Alan J Chief Scientific Officer Nov 01, 2021 Sale $18.02 469 8,454 143,373 Nov 03, 2021, 07:00 PM
Russell Alan J Chief Scientific Officer Oct 15, 2021 Sale $18.12 1,433 25,966 143,968 Oct 18, 2021, 07:48 PM
Russell Alan J Chief Scientific Officer Oct 14, 2021 Sale $18.18 5,749 104,517 145,275 Oct 18, 2021, 07:48 PM
Russell Alan J Chief Scientific Officer Oct 11, 2021 Sale $18.02 1,270 22,885 151,024 Oct 13, 2021, 06:51 PM
Russell Alan J Chief Scientific Officer Oct 06, 2021 Sale $18.03 2,108 38,007 171,214 Oct 08, 2021, 06:00 PM
Russell Alan J Chief Scientific Officer Oct 08, 2021 Sale $18.15 5,902 107,121 152,294 Oct 08, 2021, 06:00 PM
Russell Alan J Chief Scientific Officer Oct 07, 2021 Sale $18.56 13,018 241,614 158,196 Oct 08, 2021, 06:00 PM
Russell Alan J Chief Scientific Officer Oct 05, 2021 Sale $18.26 5,404 98,677 173,322 Oct 05, 2021, 06:33 PM
Russell Alan J Chief Scientific Officer Oct 04, 2021 Sale $18.00 100 1,800 178,726 Oct 05, 2021, 06:33 PM
Russell Alan J Chief Scientific Officer Oct 01, 2021 Sale $18.00 274 4,932 178,826 Oct 05, 2021, 06:33 PM
Russell Alan J Chief Scientific Officer Sep 28, 2021 Sale $17.30 14,610 252,753 190,944 Sep 30, 2021, 07:16 PM
Russell Alan J Chief Scientific Officer Sep 29, 2021 Sale $16.86 11,844 199,730 179,718 Sep 30, 2021, 07:16 PM
Russell Alan J Chief Scientific Officer Sep 27, 2021 Sale $17.98 11,611 208,774 205,571 Sep 27, 2021, 07:32 PM
Russell Alan J Chief Scientific Officer Sep 24, 2021 Sale $18.16 20,100 365,016 217,165 Sep 27, 2021, 07:32 PM
Russell Alan J Chief Scientific Officer Sep 23, 2021 Sale $18.54 26,835 497,632 242,337 Sep 27, 2021, 07:32 PM
ROOT JONATHAN D Director Mar 30, 2021 Buy $16.00 15,625 250,000 15,625 Mar 31, 2021, 07:12 PM
Thompson Peter A. Director Mar 30, 2021 Buy $16.00 359,375 5,750,000 13,359,456 Mar 31, 2021, 07:11 PM
ORBIMED ADVISORS LLC Director Mar 30, 2021 Buy $16.00 359,375 5,750,000 13,359,456 Mar 31, 2021, 07:10 PM
Novo Holdings A/S 10% Owner Mar 30, 2021 Buy $16.00 625,000 10,000,000 5,587,207 Mar 31, 2021, 04:36 PM
Flynn James E 10% Owner Mar 30, 2021 Buy $16.00 625,000 10,000,000 3,933,137 Mar 30, 2021, 03:42 PM
Load More Insider Transactions
Buy Sale Option Exercise
Owner Relationship Date Value($)
Carruthers R Michael Chief Financial Officer 05/23/2022 6,390
ORBIMED ADVISORS LLC Director 05/18/2022 994,980
Thompson Peter A. Director 05/18/2022 994,980
MOORE JOHN R General Counsel 05/16/2022 80,146
MOORE JOHN R General Counsel 01/21/2022 3,834
MOORE JOHN R General Counsel 12/28/2021 3,834
Russell Alan J Chief Scientific Officer 11/30/2021 37,815
Russell Alan J Chief Scientific Officer 11/15/2021 9,155
Russell Alan J Chief Scientific Officer 11/12/2021 167,074
Russell Alan J Chief Scientific Officer 11/11/2021 384,238
Russell Alan J Chief Scientific Officer 11/10/2021 243,170
Russell Alan J Chief Scientific Officer 11/09/2021 594,306
Russell Alan J Chief Scientific Officer 11/08/2021 181,824
Russell Alan J Chief Scientific Officer 11/05/2021 255,907
Russell Alan J Chief Scientific Officer 11/04/2021 146,092
Russell Alan J Chief Scientific Officer 11/03/2021 476,096
Russell Alan J Chief Scientific Officer 11/02/2021 305,360
Russell Alan J Chief Scientific Officer 11/01/2021 8,454
Russell Alan J Chief Scientific Officer 10/15/2021 25,966
Russell Alan J Chief Scientific Officer 10/14/2021 104,517
Russell Alan J Chief Scientific Officer 10/11/2021 22,885
Russell Alan J Chief Scientific Officer 10/06/2021 38,007
Russell Alan J Chief Scientific Officer 10/08/2021 107,121
Russell Alan J Chief Scientific Officer 10/07/2021 241,614
Russell Alan J Chief Scientific Officer 10/05/2021 98,677
Russell Alan J Chief Scientific Officer 10/04/2021 1,800
Russell Alan J Chief Scientific Officer 10/01/2021 4,932
Russell Alan J Chief Scientific Officer 09/28/2021 252,753
Russell Alan J Chief Scientific Officer 09/29/2021 199,730
Russell Alan J Chief Scientific Officer 09/27/2021 208,774
Russell Alan J Chief Scientific Officer 09/24/2021 365,016
Russell Alan J Chief Scientific Officer 09/23/2021 497,632
ROOT JONATHAN D Director 03/30/2021 250,000
Thompson Peter A. Director 03/30/2021 5,750,000
ORBIMED ADVISORS LLC Director 03/30/2021 5,750,000
Novo Holdings A/S 10% Owner 03/30/2021 10,000,000
Flynn James E 10% Owner 03/30/2021 10,000,000
Load More Insider Transactions